Review: The treatment of irritable bowel syndrome
- 8 June 2009
- journal article
- Published by SAGE Publications in Therapeutic Advances in Gastroenterology
- Vol. 2 (4), 221-238
- https://doi.org/10.1177/1756283x09104794
Abstract
Irritable bowel syndrome (IBS) is a highly prevalent functional bowel disorder routinely encountered by healthcare providers. Although not life-threatening, this chronic disorder reduces patients' quality of life and imposes a significant economic burden to the healthcare system. IBS is no longer considered a diagnosis of exclusion that can only be made after performing a battery of expensive diagnostic tests. Rather, IBS should be confidently diagnosed in the clinic at the time of the first visit using the Rome III criteria and a careful history and physical examination. Treatment options for IBS have increased in number in the past decade and clinicians should not be limited to using only fiber supplements and smooth muscle relaxants. Although all patients with IBS have symptoms of abdominal pain and disordered defecation, treatment needs to be individualized and should focus on the predominant symptom. This paper will review therapeutic options for the treatment of IBS using a tailored approach based on the predominant symptom. Abdominal pain, bloating, constipation and diarrhea are the four main symptoms that can be addressed using a combination of dietary interventions and medications. Treatment options include probiotics, antibiotics, tricyclic antidepressants, selective serotonin reuptake inhibitors and agents that modulate chloride channels and serotonin. Each class of agent will be reviewed using the latest data from the literature.Keywords
This publication has 115 references indexed in Scilit:
- Effects of pregabalin on visceral pain responses and colonic compliance in ratsBritish Journal of Pharmacology, 2008
- T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained ResponseGastroenterology, 2008
- Guidelines on the irritable bowel syndrome: mechanisms and practical managementGut, 2007
- Small intestinal bacterial overgrowth in patients with irritable bowel syndromeGut, 2007
- Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled TrialDigestive Diseases and Sciences, 2007
- Effect of a second-generation 2 ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndromeGut, 2007
- The Efficacy of an Herbal Medicine, Carmint, on the Relief of Abdominal Pain and Bloating in Patients with Irritable Bowel Syndrome: A Pilot StudyDigestive Diseases and Sciences, 2006
- U. S. Householder survey of functional gastrointestinal disordersDigestive Diseases and Sciences, 1993
- Effects of desipramine on irritable bowel syndrome compared with atropine and placeboDigestive Diseases and Sciences, 1987
- Role of loperamide and placebo in management of irritable bowel syndrome (IBS)Digestive Diseases and Sciences, 1984